EU pandemic‑preparedness push

The European Union is trying to lock in faster vaccine and drug production before the next pandemic, and it wants pharmaceutical companies to agree to terms in advance. (health.ec.europa.eu) The push sits inside the European Commission’s new medical countermeasures strategy, published on July 9, 2025, which says the bloc needs stronger development, production, stockpiling and procurement for health emergencies. (health.ec.europa.eu) The European Health Emergency Preparedness and Response Authority, known as HERA, is the unit running much of that work. The Commission says HERA was created after the early COVID-19 response to secure the availability and accessibility of medicines, vaccines and other emergency tools across the bloc. (health.ec.europa.eu) In plain terms, the European Union wants factories, contracts and supply chains lined up before a crisis hits, instead of bargaining country by country after shortages start. HERA’s preparedness work includes joint procurement, stockpiling, threat assessment and a common research agenda for pandemic readiness. (health.ec.europa.eu) The evidence problem is separate from the factory problem. The European Medicines Agency says its crisis role now includes faster approval support, shortage monitoring and coordination during public health emergencies, which is meant to help regulators make decisions when data is still incomplete. (ema.europa.eu) Cross-border coordination is the third pillar. The Council of the European Union says the post-COVID health security framework was rewritten to give the European Union stronger rules on serious cross-border health threats and a more operational role for European agencies. (consilium.europa.eu) That architecture now includes a Union prevention, preparedness and response plan for health crises. The Commission says the plan sets out joint governance, shared tools for crisis managers and regional cross-border cooperation for European Union and European Economic Area countries. (health.ec.europa.eu) The research side is also being expanded. On February 17, 2026, the Commission launched the BE READY European Partnership, bringing together 81 organisations from 27 countries to strengthen pandemic-preparedness research under the European Union’s Horizon Europe program. (health.ec.europa.eu) The pharmaceutical industry is also facing a broader rewrite of European Union drug rules at the same time. The Council and European Parliament reached political agreement on the pharma package on December 11, 2025, and the European Medicines Agency says the final legal text and operational changes are still being detailed in 2026. (consilium.europa.eu) The practical question now is whether Brussels can get “workable terms” that keep companies investing in capacity before an outbreak and still let governments move quickly when one starts. The European Union has already built the agencies, plans and legal framework; this phase is about making them work under pressure. (health.ec.europa.eu)